The Goldman Sachs Group Begins Coverage on Beta Bionics (NASDAQ:BBNX)
The Goldman Sachs Group assumed coverage on shares of Beta Bionics (NASDAQ:BBNX – Free Report) in a research report report published on Friday morning, MarketBeat reports. The brokerage issued a neutral rating and a $16.00 price target on the stock. A number of other analysts also recently weighed in on BBNX. LADENBURG THALM/SH SH started […]
The Goldman Sachs Group assumed coverage on shares of Beta Bionics (NASDAQ:BBNX – Free Report) in a research report report published on Friday morning, MarketBeat reports. The brokerage issued a neutral rating and a $16.00 price target on the stock. A number of other analysts also recently weighed in on BBNX. LADENBURG THALM/SH SH started […]
